Last updated at 05 Dec 2024 09:57 AM
Director
DIN: 03168281
Bimal Mukesh Shah is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at SUN MEDIPHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03168281.Bimal Mukesh Shah has previously been associated with 1 company in roles such as Director.Bimal Mukesh Shah is currently involved in 2 different roles. Their most recent position is with S AND S PHARMACY LLP as a Designated Partner. The first company Bimal Mukesh Shah was appointed to as a director was SUN MEDIPHARMA PRIVATE LIMITED. Bimal Mukesh Shah is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
Bimal Mukesh Shah is currently associated with 3 companies in various capacities such as Director and Designated Partner. They serve as a Director at SUN MEDIPHARMA PRIVATE LIMITED and have other roles in different companies. They are registered with the Ministry of Corporate Affairs (MCA) of India and hold a DIN of 03168281.Bimal Mukesh Shah has previously been associated with 1 company in roles such as Director.Bimal Mukesh Shah is currently involved in 2 different roles. Their most recent position is with S AND S PHARMACY LLP as a Designated Partner. The first company Bimal Mukesh Shah was appointed to as a director was SUN MEDIPHARMA PRIVATE LIMITED. Bimal Mukesh Shah is not disqualified by the Registrar of Companies under Section 164(2), and their DIN has not been deactivated due to failure to file the DIR-3 KYC Form.
3
Male
India
Gain instant access to verified contact details.
Current Companies (2)
Current LLPs (1)
Past Companies (1)
3y 1m 1y 7m Interval
| Company Name | Designation | Date of Appointment |
|---|---|---|
| SUN MEDIPHARMA PRIVATE LIMITED | Director | 10-Jan-2013 |
| EYEHEAL ORG PRIVATE LIMITED | Director | 04-Dec-2023 |